门冬胰岛素30强化治疗2型糖尿病的临床观察被引量：1

下载PDF

导出

摘要目的:比较三餐前注射门冬胰岛素30(诺和锐30)和多次重组人胰岛素(诺和灵R和诺和灵N)强化治疗2型糖尿病的疗效及安全性。方法:54例口服药物治疗血糖控制不佳的2型糖尿病患者随机分为两组:诺和锐30组(26例)每日3次诺和锐30皮下注射,诺和灵组(28例)每日4次重组人胰岛素治疗(三餐前半小时皮下注射诺和灵R,睡前皮下注射诺和灵N)。结果:两组胰岛素强化治疗方案均能有效控制血糖,其疗效及安全性无明显差异。结论:诺和锐30每日3次注射和每日4次重组人胰岛素治疗控制血糖同样有效,但需加强夜间血糖监测。

作者李红霞李小燕杨丽琴

机构地区贵阳市第六人民医院内一科

出处《贵阳医学院学报》 CAS 2011年第4期384-385,388,共3页 Journal of Guiyang Medical College

关键词糖尿病非胰岛素依赖型胰岛素门冬胰岛素重组人胰岛素胰岛素强化治疗

分类号 R587.1 [医药卫生—内分泌]

引文网络
相关文献

参考文献7

1Yang W, Ji Q, Zhu D, et al. Biphasic insulin aspart 30 three times daily is more effective than a twice-daily regimen without increasing hypoglycemia in Chinese subjects with type 2 diabetes inadequately controlled on oral antidiabetes drugs [ J ]. Diabetes Care,2008 (31 ) : 852 - 856. 被引量：1
2冯凭.2型糖尿病住院患者每日3次诺和锐30注射的血糖控制多中心研究[J].国际内分泌代谢杂志,2007,27(6):428-429. 被引量：20
3Garber AJ,Wahlen J, Wahl T, et al. Attainment of glycaemic goals in type diabetes with oncce, twice or thrice daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study) [ J ]. Diabetes Obes Metab,2006 (8) :58 - 66. 被引量：1
4杨文英,高妍,刘国良,陈露露,傅祖植,邹大进,冯凭,赵志刚.糖尿病患者接受双时相门冬胰岛素30治疗时的临床基线情况——IMPROVE^(TM)研究中国亚组结果[J].中国糖尿病杂志,2009,17(8). 被引量：15
5邓月珍,叶飞.速效胰岛素与短效胰岛素在胰岛素泵中应用的比较[J].实用临床医药杂志,2008,12(7):72-73. 被引量：3
6高妍,郭晓蕙.诺和锐30治疗2型糖尿病有效性和安全性研究——PRESENT大型临床观察研究中国区结果报道[J].中华内分泌代谢杂志,2008,24(6):616-619. 被引量：18
7Bretzel RG, Amolds S, Medding J, et al. A direct efficay and safety comparsion of insulin aspart,human soluble insulin and human premix insulin (70/30) in patients with type 2 diabetes [ J ]. Diabetes Care, 2004 ( 27 ) : 1023 - 1027. 被引量：1

二级参考文献31

1武晋晓,吕肖峰,刘福平.胰岛素泵治疗糖尿病的临床观察[J].中华内分泌代谢杂志,2005,21(3):276-277. 被引量：83
2Bode B W, Sabbah H T, Gross T M, et al. Diabetes management in the new millennium using insulin pump therapy[J]. Diabetes Metab Res Rev, 2002, 18: S14. 被引量：1
3Gammeltoft S, Hansen B F, Dideriksen L, et al. Insulin aspart: a novel rapid-acting human insulin analogue[J ]. Expert Opin Investig Drugs, 1999, 8: 1431. 被引量：1
4Perriello G, Pampanelli S, Porcellati F, et al. Insulin aspart improves meal time glycacnnic control in patients with Type 2 diabetes: a randomized, stratified, double-blind and cross-over trial[J]. Diabet Med, 2005, 22: 606. 被引量：1
5Danne T, Aman J, Schober E, et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes[J]. Diabetes Care, 2003, 26: 2359. 被引量：1
6Bonora E, Corrao G, Bagnardi V, et al. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus. Diabetologia, 2006,49:846-854. 被引量：1
7DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Diabetes Epidemiology: Collaborative analysis of diagnostic criteria in Europe. Lancet, 1999,354:617-621. 被引量：1
8UKPDS Group. Intensive blood glucose-control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes ( UKPDS 33). Lancet, 1998,352:837- 853. 被引量：1
9American Diabetes Association. Standards of medical care in diabetes- 2007. Diabetes Care, 2007,30 (suppl 1 ) :S4-S41. 被引量：1
10Wild S, Roglie G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27 : 1047-1053. 被引量：1